Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Consumer Groups Have A ‘Radical Transparency’ List For US FDA’s PDUFA VIII
Jul 24 2025
•
By
Sarah Karlin-Smith
FDA is being pushed to live up to their word on transparency when it comes to their user fee funding agreements with industry.
(Shutterstock)
More from Policy & Regulation
More from Health